Tassos Gianakakos
2019
Compensation breakdown
| Non-Equity Incentive Plan | $376,000 |
|---|---|
| Option Awards | $5,979,619 |
| Salary | $610,018 |
| Stock Awards | $3,256,932 |
| Other | $1,000 |
| Total | $10,223,569 |
Gianakakos received $6M in option awards, accounting for 58% of the total pay in 2019.
Gianakakos also received $376K in non-equity incentive plan, $610K in salary, $3.3M in stock awards and $1K in other compensation.
Rankings
In 2019, Tassos Gianakakos' compensation ranked 721st out of 13,971 executives tracked by ExecPay. In other words, Gianakakos earned more than 94.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 721 out of 13,971 | 95th |
Division Manufacturing | 250 out of 5,701 | 96th |
Major group Chemicals And Allied Products | 65 out of 2,200 | 97th |
Industry group Drugs | 54 out of 1,886 | 97th |
Industry Pharmaceutical Preparations | 44 out of 1,398 | 97th |
Pay ratio
| Tassos Gianakakos' Pay | $10,223,569 |
|---|---|
| Median Employee's Pay | $268,172 |
| Pay Ratio | 38to 1 |
In 2019, the annual total compensation of Tassos Gianakakos was $10,223,569.
The annual total compensation of the median employee at MyoKardia was $268,172.
The ratio of Tassos Gianakakos' pay to the pay of median employee was therefore 38 to one.
Gianakakos' colleagues
We found five more compensation records of executives who worked with Tassos Gianakakos at MyoKardia in 2019.
2019
William Fairey
MyoKardia
Executive Vice President, Chief Commercial Officer
2019
June Lee
MyoKardia
Executive Vice President, Chief Development Officer
2019
Robert McDowell
MyoKardia
Chief Scientific Officer
2019
Jake Bauer
MyoKardia
Chief Business Officer
2019
Taylor Harris
MyoKardia